Background-Hepatocellular carcinoma
(HCC) is one ofthe most common cancers in the world. The geographical prevalence varies considerably in different countries and Scotland is regarded as an area oflow risk for the disease. Aims-To assess the association between chronic hepatitis C infection (HCV) and HCC in a population of patients presenting to a single hospital. Patients-One hundred and fourteen cases of histologically confirmed liver cancer presenting to the Royal Infirmary of Edinburgh between 1985 and 1994 were examined. Methods-Of 114 cases of HCC, 80 samples of stored sera were available. Samples positive for HCV Ab were genotyped by restriction fragment length polymorphism analysis of HCV c-DNA. A population of 29 cirrhotic patients (diagnosed between 1985 and 1994) with chronic HCV infection was also genotyped. Results-Chronic HCV infection was a major risk factor (30% of tested HCC patients) identified. HCV genotype lb was predominant (16 of 20 patients) . The time from HCV transmission to development of cancer ranged from 10 to 50 years (median 30). In the cirrhotic patient population, a broader distribution of genotypes was present ( Serological markers of HBV infection were detected with standard assays (RIA, Abbott laboratories, Weisbaden, Germany).
Anti-HCV antibodies were detected by a second generation enzyme immunoassay (EIA, Abbot laboratories, Weisbaden, Germany) and also by third generation recombinant immunoblot assays (RIBA-3, Chiron, Emeryville, CA) for antibody to non-structural proteins 5-1-1 (NS4), c-100-3 (NS4), c33c (NS3), and coreassociated antigen c-22-3.
A population of cirrhotic patients (n=29; 22 male; mean (SD) age: 52 (14-5) years), presenting during the same time period (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) , was also examined. All had chronic hepatitis C infection; a significant proportion had previously been diagnosed as having 'cryptogenic' cirrhosis.
RNA extraction Viral RNA was extracted from 0 5 ml of stored serum from each of the patients as previously described. 20 Briefly, serum samples were incubated at 37°C for 1 5 hours with 1 mg/ml proteinase K in the presence of 40 ,ug/ml polyadenylic acid, 0-5% SDS, 0-1 M NaCl, 50 mM TRIS HCL (pH 8 0), and 1 mM EDTA. Nucleic acid was extracted successively with phenol and chloroform-isoamyl alcohol (50:1) and precipitated by the addition of one tenth volume of sodium acetate (pH 5 (Fig 2) .
In the whole HCC population, cirrhosis preceded HCC in 66 (82-/5%) cases; other pathology was demonstrated in eight (10%), and it was unclassified (because the tumour alone was biopsied) in six (7 5%).
Discussion
In this study, we have identified chronic HCV infection as a major risk factor for the development of HCC in a Scottish population, a finding already made in high risk aeras of HCC, such as Japan, Italy, and Spain.4
There is a strong association between chronic HCV infection and hepatocarcinogenesis, through the pathway of chronic liver injury, regeneration, and cirrhosis; cirrhosis preceded HCC in 20 of 24 (83%) of our cases (Fig 2) . In Western countries, the cancer commonly occurs late in life, mostly in cirrhotic nodules.24 25 Our study supports this finding; the patients were elderly and most were infected after receiving blood transfusions a median time of 30 years previously. This is a similar time period to that noted in a recent study from Spain, which found the interval between the date of blood transfusion and the diagnosis of HCC to be 26-8 (12-4) years.20
However, in three of our cases, a tumour developed from a normal or hepatitic liver; further evidence for the persistence and replication of HCV genomes in primary liver cancer developing in the absence of cirrhosis or other risk factors.27 In these cases, the mode of hepatocarcinogenesis is unclear; HCV lacks reverse transcriptase activity and is not thought to be associated with genomic integration, while little is known about the biological properties of HCV proteins. Certainly, the mechanism is different to hepatitis B virus (HBV). HBV is believed to be directly oncogenic either by HBV integration causing increased genomic instability or by transactivation of cellular genes.28 30 Cofactors to HCV seropositivity in the development of HCC were noted in four patients; either current HBV infection (two patients) or alcohol misuse (two patients). A further six patients had markers of past hepatitis B infection (HBsAg negative; anti-HBs, and anti-HBc positive). HBV may still be implicated in these cancers because its DNA can persist in both serum and liver of patients with serology of past infection. Alcohol misuse 2 9 Current HBV infection 2 1
Past HBV infection 6 9 Serum RT-PCR positive (HCV RNA) 20 28 HCV genotypes (0) Genotype lb: 16 (7) (*mean (SD); tmedian (range)). In the cirrhotic population a wider distribution of genotypes was noted; however, this population was significantly younger and had a significantly shorter duration of HCV infection than the HCC population. In conclusion, these findings indicate that, in a population of Scottish patients, there is a strong association between chronic HCV infection, cirrhosis, and hepatocarcinogenesis. However, the study was unable to distinguish whether the high prevalence of genotype lb in the HCC population reflects increased oncogenicity in itself, or simply a background epidemiology of the most prevalent genotype, a median time of 30 years ago. Larger, population based studies are required to confirm that HCV genotypes vary in their propensity to produce clinically significant liver disease; and to establish the role of cofactors and the host response in these processes.
